23 Osenniy Boulvar, BC Krylatsky
121609, Russia, Moscow

Company History

Year of foundation of the SPEY

Production of the first products
Production of the company's first products on the production lines of European partners.
Expanding the geographical presence
Opening of representative offices in Kazakhstan, Kyrgyzstan, Turkmenistan and Tajikistan.
First registration certificates
Obtaining the first registration certificates in the countries of the company's presence.
Start of sales
Start of sales of SPEY drugs in Kazakhstan and Kyrgyzstan.
The emergence of a representative office in India
Opening of a regional office in India.
Entry to the markets of Georgia and Armenia
More than 50 registered names of drugs in the countries of presence.
Strengthening the position
Strengthening the position in Eastern Europe.
Opening of an office in Skopje, Macedonia.
Registration of the SPEY company in the Russian Federation
Registration of the SPEY company in the Russian Federation and the beginning of registration of drugs.
Expanding the geographical presence
Expanding its geographical presence in Southeast Asian countries such as Vietnam, the Philippines, Myanmar and Cambodia.
Start of sales in Uzbekistan
Start of sales of SPEY drugs in Uzbekistan.
Achieving an annual turnover of 85 million US dollars.
Expanding the geographical presence in Latin America
Entry to the Dominican Republic market.
300 registered names of drugs in the countries of presence.
Registration in Ukraine
The beginning of the registration process of SPEY drugs in Ukraine.
Present time

SPEY is an international pharmaceutical company founded in 2001.

Our company is engaged in the development and marketing of high-quality and innovative pharmaceutical products for the needs of a wide range of therapeutic areas. All products are manufactured at production facilities equipped with advanced technology and approved by the world quality standards of the World Health Organization (WHO) and Good Manufacturing Practice (GMP).

In a short period of time, SPEY has become one of the most dynamically developing global pharmaceutical companies, with business connections in more than 20 countries around the world. Among them: Russia, Armenia, Azerbaijan, Georgia, CIS countries (Kazakhstan, Tajikistan, Uzbekistan, Turkmenistan and Kyrgyzstan), India, Nepal, Mongolia, Southeast Asian countries (Philippines, Vietnam, Cambodia, Myanmar) and markets in Africa and Latin America.

In today's society, SPEY strives to improve the quality of life of people with effective and affordable medicines. We are sure that successful projects are born from good ideas and their high-quality execution together with great talent.

Your browser is outdated, we recommend that you update it to the latest version
or use another one.